{"id":"https://openalex.org/W85580240","doi":null,"title":"A new slow-release form of 5-aminosalicylic acid for the oral treatment of inflammatory bowel disease. Biopharmaceutic and clinical pharmacokinetic characteristics.","display_name":"A new slow-release form of 5-aminosalicylic acid for the oral treatment of inflammatory bowel disease. Biopharmaceutic and clinical pharmacokinetic characteristics.","publication_year":1985,"publication_date":"1985-01-01","ids":{"openalex":"https://openalex.org/W85580240","mag":"85580240","pmid":"https://pubmed.ncbi.nlm.nih.gov/4039590"},"language":"en","primary_location":{"id":"pmid:4039590","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4039590","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025524243","display_name":"Ulrich E. Klotz","orcid":"https://orcid.org/0000-0002-6033-1659","observed_orcids":["https://orcid.org/0000-0002-6033-1659"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"U Klotz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109052520","display_name":"K. Maier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K E Maier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"C Fischer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Fischer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060697070","display_name":"Kurt Bauer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K H Bauer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.7438,"has_fulltext":false,"cited_by_count":48,"citation_normalized_percentile":{"value":0.91705571,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"35","issue":"3","first_page":"636","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-aminosalicylic-acid","display_name":"5-aminosalicylic acid","score":1.0},{"id":"https://openalex.org/keywords/enteric-coated-tablets","display_name":"enteric-coated tablets","score":0.7749999761581421},{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":0.9150000214576721},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":1.0},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9369999766349792},{"id":"https://openalex.org/keywords/n-acetyl-5-aminosalicylic-acid","display_name":"N-acetyl-5-aminosalicylic acid","score":0.9890000224113464},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.8539999723434448},{"id":"https://openalex.org/keywords/steady-state-plasma-concentration","display_name":"steady-state plasma concentration","score":0.8730000257492065},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.7820000052452087},{"id":"https://openalex.org/keywords/oral-drug-delivery","display_name":"oral drug delivery","score":0.6480000019073486}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8524453639984131},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.7696164846420288},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.7401195168495178},{"id":"https://openalex.org/C2776206795","wikidata":"https://www.wikidata.org/wiki/Q2823237","display_name":"Aminosalicylic acid","level":2,"score":0.703777551651001},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.6431471705436707},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6415552496910095},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.6274042725563049},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5839025378227234},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5409037470817566},{"id":"https://openalex.org/C149151106","wikidata":"https://www.wikidata.org/wiki/Q4677569","display_name":"Active metabolite","level":3,"score":0.5187697410583496},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5063720941543579},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.21061435341835022}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000636","descriptor_name":"Aminosalicylic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000636","descriptor_name":"Aminosalicylic Acids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000636","descriptor_name":"Aminosalicylic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001702","descriptor_name":"Biopharmaceutics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003424","descriptor_name":"Crohn Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005243","descriptor_name":"Feces","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013608","descriptor_name":"Tablets, Enteric-Coated","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019804","descriptor_name":"Mesalamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:4039590","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4039590","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arzneimittel-Forschung","raw_type":"Journal Article"},{"id":"mag:85580240","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/4039590","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2040547481","https://openalex.org/W2045297728","https://openalex.org/W2007418676","https://openalex.org/W2010946554","https://openalex.org/W2081146907","https://openalex.org/W1993020837","https://openalex.org/W2072029446","https://openalex.org/W46487029","https://openalex.org/W2073759704","https://openalex.org/W99915630"],"abstract_inverted_index":{"A":[0],"new":[1,166],"enteric":[2],"coated":[3],"form":[4,169],"of":[5,13,32,75,95,131,173],"5-aminosalicylic":[6],"acid":[7],"(5-AS,":[8],"Salofalk)":[9],"for":[10,115,177],"the":[11,29,92,159,165],"treatment":[12,43],"inflammatory":[14,185],"bowel":[15,186],"disease":[16,25],"was":[17,40,134],"developed.":[18],"In":[19,157],"11":[20],"hospitalized":[21],"patients":[22,183],"with":[23,44,91,184],"Crohn's":[24],"or":[26],"ulcerative":[27],"colitis":[28],"steady-state":[30,71],"pharmacokinetics":[31],"5-AS":[33,47,76,98,116,133,176],"and":[34,69,77,84,121,128,140,179],"its":[35],"major":[36],"metabolite,":[37],"N-acetyl-5-AS":[38],"(Ac-5-AS),":[39],"investigated.":[41],"During":[42],"0.5":[45],"g":[46,97],"tid":[48,99],"elimination":[49],"half-life":[50],"(t":[51],"1/2)":[52],"ranged":[53],"from":[54],"0.7":[55,80],"to":[56,136,150],"2.4":[57],"h":[58],"(1.4":[59],"+/-":[60,64,81,86,110,118,124,138,142],"0.6":[61],"h,":[62],"mean":[63,70],"SD;":[65],"n":[66],"=":[67,101],"6)":[68],"plasma":[72,151],"levels":[73],"(Css)":[74],"Ac-5-AS":[78,122],"averaged":[79],"0.4":[82],"micrograms/ml":[83],"1.2":[85],"0.3":[87],"micrograms/ml,":[88],"respectively.":[89,144],"Treatment":[90],"smaller":[93],"dose":[94],"0.25":[96],"(n":[100],"5)":[102],"resulted":[103],"in":[104,182],"a":[105],"shorter":[106],"t":[107],"1/2":[108],"(0.6":[109],"0.2":[111,119,125],"h),":[112],"lower":[113],"Css":[114],"(0.4":[117],"micrograms/ml)":[120],"(1.0":[123],"micrograms/ml).":[126],"Urinary":[127],"fecal":[129],"recovery":[130],"total":[132],"calculated":[135],"44":[137],"21%":[139],"35":[141],"10%,":[143],"Both":[145],"compounds":[146],"were":[147],"slightly":[148],"bound":[149],"proteins":[152],"(5-AS:":[153],"43%,":[154],"Ac-5-AS:":[155],"78%).":[156],"conclusion,":[158],"present":[160],"data":[161],"would":[162],"suggest":[163],"that":[164],"oral":[167],"dosage":[168],"delivers":[170],"sufficient":[171],"amounts":[172],"therapeutically":[174],"active":[175],"local":[178],"systemic":[180],"action":[181],"disease.":[187]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}